MAPT and Alzheimer disease: To explore the effect of C004019 on the pathological tau in AD mouse models, we infused C004019 (5 μL, 200 μM) into the lateral ventricles of 9.5 m-old 3xTg-AD mice which contained prominent tau pathology 19, 20.